UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Critical Telehealth and Healthcare Utilization during COVID-19 in Sickle Cell Disease: CBO Reach in Understanding the Patient Experience

Blood, 2020-11, Vol.136 (Supplement 1), p.32-33

2020

Volltextzugriff (PDF)

Managing sickle cell disease

BMJ, 2003-11, Vol.327 (7424), p.1151-1155

International edition, 2003

Volltextzugriff (PDF)

Poor Access to Care Is a Risk Factor for Iron Overload in Adults with Sickle Cell Disease in Southern California

Blood, 2018-11, Vol.132 (Supplement 1), p.3527-3527

2018

Volltextzugriff (PDF)

Biology of Anemia, Differential Diagnosis, and Treatment Options in Human Immunodeficiency Virus Infection

The Journal of infectious diseases, 2002-05, Vol.185 (Supplement-2), p.S105-S109

Claster, Susan

2002

Volltextzugriff (PDF)

Improving Access to Care for Adults with Sickle Cell Disease in Los Angeles County

Blood, 2017-12, Vol.130, p.4656-4656

2017

Volltextzugriff (PDF)

Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects

Blood advances, 2020-08, Vol.4 (16), p.3804-3813

2020

Volltextzugriff (PDF)

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment

JAMA : the journal of the American Medical Association, 2003-04, Vol.289 (13), p.1645

2003

Volltextzugriff (PDF)

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia

Blood, 2008-04, Vol.111 (8), p.3991-3997

2008

Volltextzugriff (PDF)

Adding Hydroxyurea to Chronic Transfusion Therapy for Stroke in Sickle Cell Disease

Blood, 2009-11, Vol.114 (22), p.4620-4620

2009

Volltextzugriff (PDF)

Arginine Therapy: A New Treatment for Pulmonary Hypertension in Sickle Cell Disease?

American journal of respiratory and critical care medicine, 2003-07, Vol.168 (1), p.63-69

2003

Volltextzugriff (PDF)

Nutritional deficiencies in iron overloaded patients with hemoglobinopathies

American journal of hematology, 2009-06, Vol.84 (6), p.344-348

2009

Volltextzugriff (PDF)

Pitfalls of using administrative data sets to describe clinical outcomes in sickle cell disease

Pediatric blood & cancer, 2013-12, Vol.60 (12), p.1936-1939

2013

Volltextzugriff (PDF)

Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major

British journal of haematology, 2008-06, Vol.141 (6), p.891-894

2008

Volltextzugriff (PDF)

Acute Healthcare Utilization for Patients with Sickle Cell Disease within a Community Based Hospital System

Blood, 2012-11, Vol.120 (21), p.4246-4246

2012

Volltextzugriff (PDF)

Pitfalls of using administrative data sets to describe clinical outcomes in sickle cell disease: Administrative Data Sets in Sickle Cell

Pediatric blood & cancer, 2013-12, Vol.60 (12), p.1936-1939

2013

Volltextzugriff (PDF)

Biology of anemia, differential diagnosis, and treatment options in human immunodeficiency virus infections

The Journal of infectious diseases, 2002-05, Vol.185, p.S105

Claster, Susan

2002

Volltextzugriff (PDF)

Preoperative Transfusion Practices and Outcomes in Sickle Cell Patients Admitted to California Hospitals

Blood, 2011-11, Vol.118 (21), p.4189-4189

2011

Volltextzugriff (PDF)

Combination of Two Orally Active Iron Chelating Agents: Efficacy and Safety In a Clinical Setting

Blood, 2010-11, Vol.116 (21), p.2064-2064

2010

Volltextzugriff (PDF)

Use of Transfusion to Treat Acute Chest In Sickle Cell Disease:California Hospital Practice Patterns

Blood, 2010-11, Vol.116 (21), p.253-253

2010

Volltextzugriff (PDF)

Clinical trial implementation and recruitment: Lessons learned from the early closure of a randomized clinical trial

Contemporary clinical trials, 2012-03, Vol.33 (2), p.291-297

2012

Volltextzugriff (PDF)

Inpatient management of sickle cell pain: A 'snapshot' of current practice

American journal of hematology, 2012-03, Vol.87 (3), p.333-336

2012

Volltextzugriff (PDF)

Trends in Ferritin Can Be Dramatically Different From Trends in Total Body Iron and Could Lead to Erroneous Decisions in Iron Chelation Management and Discourage Adherence in Chronically Transfused Patients

Blood, 2011-11, Vol.118 (21), p.3203-3203

2011

Volltextzugriff (PDF)

Cardiac Iron Overload Causes Clinically Evident Heart Failure and Arrhythmia in Sickle Cell Anemia Patients: Evidence From Three Cases

Blood, 2011-11, Vol.118 (21), p.4846-4846

2011

Volltextzugriff (PDF)

Low Ascorbate Levels in Transfused Patients Are Associated with Correlates of Vascular Damage in Sickle Cell Disease

Blood, 2009-11, Vol.114 (22), p.2570-2570

2009

Volltextzugriff (PDF)

Nutritional Deficiencies in Chronically Transfused Hemoglobinopathy Patients

Blood, 2007-11, Vol.110 (11), p.1735-1735

2007

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(30)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(17)
Adult
(12)
Biological And Medical Sciences
(12)
Medical Sciences
(11)
Hematology
(9)
Male
(9)
Adolescent
(8)
Female
(8)
Anemia, Sickle Cell - Complications
(7)
Child
(7)
Hematologic And Hematopoietic Diseases
(6)
Anemias. Hemoglobinopathies
(5)
Diseases Of Red Blood Cells
(5)
General & Internal Medicine
(5)
Middle Aged
(5)
Sickle Cell Disease
(5)
Anemia, Sickle Cell - Drug Therapy
(4)
Treatment Outcome
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Critical Telehealth and Healthcare Utilization during COVID-19 in Sickle Cell Disease: CBO Reach in Understanding the Patient Experience

Managing sickle cell disease

Poor Access to Care Is a Risk Factor for Iron Overload in Adults with Sickle Cell Disease in Southern California

Biology of Anemia, Differential Diagnosis, and Treatment Options in Human Immunodeficiency Virus Infection

Improving Access to Care for Adults with Sickle Cell Disease in Los Angeles County

Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia

Adding Hydroxyurea to Chronic Transfusion Therapy for Stroke in Sickle Cell Disease

Arginine Therapy: A New Treatment for Pulmonary Hypertension in Sickle Cell Disease?

Nutritional deficiencies in iron overloaded patients with hemoglobinopathies

Pitfalls of using administrative data sets to describe clinical outcomes in sickle cell disease

Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major

Acute Healthcare Utilization for Patients with Sickle Cell Disease within a Community Based Hospital System

Pitfalls of using administrative data sets to describe clinical outcomes in sickle cell disease: Administrative Data Sets in Sickle Cell

Biology of anemia, differential diagnosis, and treatment options in human immunodeficiency virus infections

Preoperative Transfusion Practices and Outcomes in Sickle Cell Patients Admitted to California Hospitals

Combination of Two Orally Active Iron Chelating Agents: Efficacy and Safety In a Clinical Setting

Use of Transfusion to Treat Acute Chest In Sickle Cell Disease:California Hospital Practice Patterns

Clinical trial implementation and recruitment: Lessons learned from the early closure of a randomized clinical trial

Inpatient management of sickle cell pain: A 'snapshot' of current practice

Trends in Ferritin Can Be Dramatically Different From Trends in Total Body Iron and Could Lead to Erroneous Decisions in Iron Chelation Management and Discourage Adherence in Chronically Transfused Patients

Cardiac Iron Overload Causes Clinically Evident Heart Failure and Arrhythmia in Sickle Cell Anemia Patients: Evidence From Three Cases

Low Ascorbate Levels in Transfused Patients Are Associated with Correlates of Vascular Damage in Sickle Cell Disease

Nutritional Deficiencies in Chronically Transfused Hemoglobinopathy Patients

Aktive Filter

Suchergebnisse filtern